Cargando…
Pharmacological Treatment of the Pathogenetic Defects in Type 2 Diabetes: The randomized multicenter South Danish Diabetes Study
OBJECTIVE: To determine the effect of treatment with insulin aspart compared with NPH insulin, together with metformin/placebo and rosiglitazone/placebo. The hypothesis was that combined correction of major pathogenetic defects in type 2 diabetes would result in optimal glycemic control. RESEARCH DE...
Autores principales: | Gram, Jeppe, Henriksen, Jan Erik, Grodum, Ellen, Juhl, Henning, Hansen, Tony Bill, Christiansen, Christian, Yderstræde, Knud, Gjessing, Hans, Hansen, Henrik M., Vestergaard, Vibe, Hangaard, Jørgen, Beck-Nielsen, Henning |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
American Diabetes Association
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3005476/ https://www.ncbi.nlm.nih.gov/pubmed/20929990 http://dx.doi.org/10.2337/dc10-0531 |
Ejemplares similares
-
The Danish Centre for Strategic Research in Type 2 Diabetes (DD2) Project: rationale and planned nationwide studies of genetic predictors, physical exercise, and individualized pharmacological treatment
por: Steffensen, Charlotte, et al.
Publicado: (2012) -
The Danish national type 2 diabetes cohort – the DD2 study
por: Sørensen, Henrik Toft, et al.
Publicado: (2012) -
Studies of association of AGPAT6 variants with type 2 diabetes and related metabolic phenotypes in 12,068 Danes
por: Snogdal, Lena Sønder, et al.
Publicado: (2013) -
Type 2 diabetes classification: a data-driven cluster study of the Danish Centre for Strategic Research in Type 2 Diabetes (DD2) cohort
por: Christensen, Diana Hedevang, et al.
Publicado: (2022) -
Danish Centre for Strategic Research in Type 2 Diabetes (DD2) project cohort of newly diagnosed patients with type 2 diabetes: a cohort profile
por: Christensen, Diana Hedevang, et al.
Publicado: (2018)